This localization of PELP1 was determined to promote an advanced cancer phenotype, with hallmarks being aberrant involvement in cytosolic signaling pathways (i.e., MAPK and AKT activation) that presumably promote extranuclear estrogen responses and fostering cancer cell resistance to Tamoxifen23,25,44–46. This evidence concerns the gene PELP1 and cancer.